Carcinoma, Hepatocellular  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00058487: Epirubicin and Thalidomide in Treating Patients With Liver Cancer

Completed
2
12
US
epirubicin hydrochloride, thalidomide
Dana-Farber Cancer Institute, National Cancer Institute (NCI)
Liver Cancer
 
01/07
NCT00820053: A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection

Completed
2
450
RoW
epirubicin and lipiodol, transarterial chemoembolization
Eastern Hepatobiliary Surgery Hospital
Hepatocellular Carcinoma
12/09
12/10
SIRTACE, NCT00867750 / 2006-006478-79: SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma

Completed
2
28
Europe
Radioembolisation (SIR-Spheres® microspheres), Transarterial Chemoembolisation
Sirtex Medical
Hepatocellular Carcinoma
06/11
06/11
NCT00057980: Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

Completed
1/2
8
US
celecoxib, epirubicin hydrochloride
Northwestern University, National Cancer Institute (NCI)
Liver Cancer
02/07
02/07

Download Options